d-arabino-2-desoxyhexose
Small moleculeexperimental
Clinical trial activity
3 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2004 (NCT00096707)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 2-deoxy-d-arabino-hexose
- 2-deoxy-d-arabino-hexose
- 2-deoxy-d-glucose
- 2-deoxy-d-glucose
- 2-deoxy-d-glucose
- 2-deoxyglucose
- 2-deoxyglucose
- 2-deoxyglucose
- 2-dg
- 2-dg
- d-arabino-2-desoxyhexose
- d-arabino-2-desoxyhexose
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00633087 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2006 | Department of Defense, Rutgers University |
| NCT00247403 | Phase 1 | Oct 1, 2005 | University of Iowa |
| NCT00096707 | Phase 1 | Feb 1, 2004 | Threshold Pharmaceuticals, University of Miami |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Department of Defense | Government | 1 | 0 | 1 | 2006 |
| Rutgers University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Threshold Pharmaceuticals | For profit | 1 | 1 | 1 | 2004 |
| University of Iowa | Academic/Hospital | 1 | 1 | 1 | 2005 |
| University of Miami | Academic/Hospital | 1 | 0 | 1 | 2004 |
5 organizations
Page 1 / 1